Report Detail
Global Radiopharmaceutical Injector Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM3808134 |
- 21 October, 2023 |
- Global |
- 90 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Radiopharmaceutical Injector market size was valued at USD 28 million in 2022 and is forecast to a readjusted size of USD 45 million by 2029 with a CAGR of 7.0% during review period.
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient's body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient's body and accurate imaging or therapeutic results.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
The Global Info Research report includes an overview of the development of the Radiopharmaceutical Injector industry chain, the market status of Hospitals and Clinics (PET Radioactive Drugs Injector, PET and SPECT Radioactive Drugs Injector), R&D Institution (PET Radioactive Drugs Injector, PET and SPECT Radioactive Drugs Injector), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radiopharmaceutical Injector.
Regionally, the report analyzes the Radiopharmaceutical Injector markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radiopharmaceutical Injector market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radiopharmaceutical Injector market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radiopharmaceutical Injector industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., PET Radioactive Drugs Injector, PET and SPECT Radioactive Drugs Injector).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radiopharmaceutical Injector market.
Regional Analysis: The report involves examining the Radiopharmaceutical Injector market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radiopharmaceutical Injector market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radiopharmaceutical Injector:
Company Analysis: Report covers individual Radiopharmaceutical Injector manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radiopharmaceutical Injector This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, R&D Institution).
Technology Analysis: Report covers specific technologies relevant to Radiopharmaceutical Injector. It assesses the current state, advancements, and potential future developments in Radiopharmaceutical Injector areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radiopharmaceutical Injector market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radiopharmaceutical Injector market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Market segment by Application
Hospitals and Clinics
R&D Institution
Major players covered
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical Injector product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical Injector, with price, sales, revenue and global market share of Radiopharmaceutical Injector from 2018 to 2023.
Chapter 3, the Radiopharmaceutical Injector competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical Injector breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceutical Injector market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical Injector.
Chapter 14 and 15, to describe Radiopharmaceutical Injector sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Radiopharmaceutical Injector
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Radiopharmaceutical Injector Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 PET Radioactive Drugs Injector
- 1.3.3 PET and SPECT Radioactive Drugs Injector
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Radiopharmaceutical Injector Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals and Clinics
- 1.4.3 R&D Institution
- 1.5 Global Radiopharmaceutical Injector Market Size & Forecast
- 1.5.1 Global Radiopharmaceutical Injector Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Radiopharmaceutical Injector Sales Quantity (2018-2029)
- 1.5.3 Global Radiopharmaceutical Injector Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Medrad, Inc.(Bayer)
- 2.1.1 Medrad, Inc.(Bayer) Details
- 2.1.2 Medrad, Inc.(Bayer) Major Business
- 2.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product and Services
- 2.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Medrad, Inc.(Bayer) Recent Developments/Updates
- 2.2 UNIVERSAL GIKEN
- 2.2.1 UNIVERSAL GIKEN Details
- 2.2.2 UNIVERSAL GIKEN Major Business
- 2.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Product and Services
- 2.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 UNIVERSAL GIKEN Recent Developments/Updates
- 2.3 Comecer
- 2.3.1 Comecer Details
- 2.3.2 Comecer Major Business
- 2.3.3 Comecer Radiopharmaceutical Injector Product and Services
- 2.3.4 Comecer Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Comecer Recent Developments/Updates
- 2.4 Sumitomo Heavy Industries
- 2.4.1 Sumitomo Heavy Industries Details
- 2.4.2 Sumitomo Heavy Industries Major Business
- 2.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Product and Services
- 2.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Sumitomo Heavy Industries Recent Developments/Updates
- 2.5 Tema Sinergie
- 2.5.1 Tema Sinergie Details
- 2.5.2 Tema Sinergie Major Business
- 2.5.3 Tema Sinergie Radiopharmaceutical Injector Product and Services
- 2.5.4 Tema Sinergie Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Tema Sinergie Recent Developments/Updates
- 2.6 Lemer Pax
- 2.6.1 Lemer Pax Details
- 2.6.2 Lemer Pax Major Business
- 2.6.3 Lemer Pax Radiopharmaceutical Injector Product and Services
- 2.6.4 Lemer Pax Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Lemer Pax Recent Developments/Updates
- 2.7 BQSV
- 2.7.1 BQSV Details
- 2.7.2 BQSV Major Business
- 2.7.3 BQSV Radiopharmaceutical Injector Product and Services
- 2.7.4 BQSV Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 BQSV Recent Developments/Updates
3 Competitive Environment: Radiopharmaceutical Injector by Manufacturer
- 3.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Radiopharmaceutical Injector Revenue by Manufacturer (2018-2023)
- 3.3 Global Radiopharmaceutical Injector Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Radiopharmaceutical Injector by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Radiopharmaceutical Injector Manufacturer Market Share in 2022
- 3.4.2 Top 6 Radiopharmaceutical Injector Manufacturer Market Share in 2022
- 3.5 Radiopharmaceutical Injector Market: Overall Company Footprint Analysis
- 3.5.1 Radiopharmaceutical Injector Market: Region Footprint
- 3.5.2 Radiopharmaceutical Injector Market: Company Product Type Footprint
- 3.5.3 Radiopharmaceutical Injector Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Radiopharmaceutical Injector Market Size by Region
- 4.1.1 Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2029)
- 4.1.2 Global Radiopharmaceutical Injector Consumption Value by Region (2018-2029)
- 4.1.3 Global Radiopharmaceutical Injector Average Price by Region (2018-2029)
- 4.2 North America Radiopharmaceutical Injector Consumption Value (2018-2029)
- 4.3 Europe Radiopharmaceutical Injector Consumption Value (2018-2029)
- 4.4 Asia-Pacific Radiopharmaceutical Injector Consumption Value (2018-2029)
- 4.5 South America Radiopharmaceutical Injector Consumption Value (2018-2029)
- 4.6 Middle East and Africa Radiopharmaceutical Injector Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 5.2 Global Radiopharmaceutical Injector Consumption Value by Type (2018-2029)
- 5.3 Global Radiopharmaceutical Injector Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 6.2 Global Radiopharmaceutical Injector Consumption Value by Application (2018-2029)
- 6.3 Global Radiopharmaceutical Injector Average Price by Application (2018-2029)
7 North America
- 7.1 North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 7.2 North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 7.3 North America Radiopharmaceutical Injector Market Size by Country
- 7.3.1 North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
- 7.3.2 North America Radiopharmaceutical Injector Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 8.2 Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 8.3 Europe Radiopharmaceutical Injector Market Size by Country
- 8.3.1 Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Radiopharmaceutical Injector Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Radiopharmaceutical Injector Market Size by Region
- 9.3.1 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Radiopharmaceutical Injector Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 10.2 South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 10.3 South America Radiopharmaceutical Injector Market Size by Country
- 10.3.1 South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
- 10.3.2 South America Radiopharmaceutical Injector Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Radiopharmaceutical Injector Market Size by Country
- 11.3.1 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Radiopharmaceutical Injector Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Radiopharmaceutical Injector Market Drivers
- 12.2 Radiopharmaceutical Injector Market Restraints
- 12.3 Radiopharmaceutical Injector Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Radiopharmaceutical Injector and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Radiopharmaceutical Injector
- 13.3 Radiopharmaceutical Injector Production Process
- 13.4 Radiopharmaceutical Injector Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Radiopharmaceutical Injector Typical Distributors
- 14.3 Radiopharmaceutical Injector Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Radiopharmaceutical Injector. Industry analysis & Market Report on Radiopharmaceutical Injector is a syndicated market report, published as Global Radiopharmaceutical Injector Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Radiopharmaceutical Injector market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
